The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Nicotine Upregulates Its Own Receptors through Enhanced Intracellular Maturation
Open accessAbstract
Chronic exposure to nicotine elicits upregulation of high-affinity nicotinic receptors in the smoker's brain. To address the molecular mechanism of upregulation, we transfected HEK293 cells with human alpha4beta2 receptors and traced the subunits throughout their intracellular biosynthesis, using metabolic labeling and immunoprecipitation techniques. We show that high-mannose glycosylated subunits mature and assemble into pentamers in the endoplasmic reticulum and that only pentameric receptors reach the cell surface following carbohydrate processing. Nicotine is shown to act inside the cell and to increase the amount of beta subunits immunoprecipitated by the conformation-dependent mAb290, indicating that nicotine enhances a critical step in the intracellular maturation of these receptors. This effect, which also takes place at concentrations of nicotine found in the blood of smokers upon expression of alpha4beta2 in SH-SY5Y neuroblastoma cells, may play a crucial role in nicotine addiction and possibly implement a model of neural plasticity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but instead appears to be attributable to occupancy of the nicotine binding site that bridges the ␣/ subunit interface of the nAChR in an immature, low-affinity conformation that facilitates glycosylation and maturation of the ␣ 4  2 nAChR to a more stable conformation with higher affinity for nicotine (Darsow et al., 2005;Sallette et al., 2005).”
From Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers (2006) · cites this paper as Sallette et al., 2005
Experimental — accuracy not yet measuredIn the citing paper
“where current evidence indicates that nicotine and presumably varenicline act to increase nAChR density by stimulating assembly of subunits into mature receptors (Sallette et al., 2004(Sallette et al., , 2005;;Kuryatov et al., 2005;Lomazzo et al., 2011;Srinivasan et al., 2011).”
From Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain (2012) · cites this paper as Sallette et al., 2005
In the citing paper
“These data correspond with previous results based on glycosylation and molecular weight measures, showing that up-regulation is initiated in the ER (Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Sallette et al., 2005
In the citing paper
“Descriptions that may be essentially equivalent to SePhaChARNS are the statements that nicotine acts as a “maturational enhancer” or a “novel slow stabilizer” for α4β2* receptors (39,50–52).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [50]
In the citing paper
“however, as discussed above, it is more likely that the quaternary drugs have sufficient membrane permeability to allow intracellular actions at the rather high concentrations (0.1–1 mM) that produce upregulation (50,65,66).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [50]
In the citing paper
“In previous studies on isolated cells, both agonists and antagonists can upregulate receptors (50,52,54,58,59).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. A. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,863
Quality control in the endoplasmic reticulum
Ellgaard, L., & Helenius, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1052 · Cited by 2,171
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationMorello, J.-P., Salahpour, A., Laperrière, A., Bernier, V., Arthus, M., Lonergan, M., Petäjä‐Repo, U. E., Angers, S., Morin, D., Bichet, D. G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8688 · Cited by 558
Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422
Cellular mechanisms of nicotine addiction
Dani, J. A., & De Biasi, M. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00652-9 · Cited by 408
Peng, X., Gerzanich, V, Anand, R., Whiting, P. J., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09730-5 · Cited by 391
Flagged first, then by citations
2 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 262
The Molecular and Cellular Neurobiology of Nicotine Abuse in Schizophrenia
Mobascher, A., & Winterer, G. (2008) · Pharmacopsychiatry · doi:10.1055/s-2008-1081463 · Cited by 50
Nicotine and Behavioral Sensitization
Mao, D., & McGehee, D. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9230-7 · Cited by 50
Poorthuis, R. B., & Mansvelder, H. D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.003 · Cited by 54
Zhao, C., Noack, C., Brackmann, M., Gloveli, T., Maelicke, A., Heinemann, U., Anand, R., & Braunewell, K. H. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.11.001 · Cited by 49
Eshaq, R. S., Stahl, L. D., Stone, R., Smith, S. S., Robinson, L. C., & Leidenheimer, N. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.030 · Cited by 47
Moss, F. J., Imoukhuede, P. I., Scott, K., Hu, J., Jankowsky, J. L., Quick, M. W., & Lester, H. A. (2009) · Journal of General Physiology · doi:10.1085/jgp.200910314 · Cited by 45
Upregulation of α7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides
Bond, C. E., Zimmermann, M., & Greenfield, S. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004846 · Cited by 45
A cognitive phenotype for a polymorphism in the nicotinic receptor gene CHRNA4
Greenwood, P. M., Parasuraman, R., & Espeseth, T. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.010 · Cited by 50
Wu, M., Puddifoot, C. A., Taylor, P., & Joiner, W. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.647248 · Cited by 45
Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors
Pandya, A. A., & Yakel, J. L. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.020 · Cited by 48
Neuronal networks of nicotine addiction
Ortells, M. O., & Arias, H. R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.019 · Cited by 44
Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation
Nashmi, R., & Lester, H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.040 · Cited by 43
Garcia‐Ratés, S., Camarasa, J., Escubedo, E., & Pubill, D. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.05.015 · Cited by 44
Breitwieser, G. E. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1370 · Cited by 43
Exley, R., Moroni, M., Sasdelli, F., Houlihan, L. M., Lukas, R., Sher, E., Zwart, R., & Bermúdez, I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03915.x · Cited by 42
Ayala-Peña, V. B., Bonini, I. C., Antollini, S. S., Kobayashi, T., & Barrantes, F. J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23254 · Cited by 42
Kenny, A. V., Cousins, S. L., Pinho, L., & Stephenson, F. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804023200 · Cited by 41
Beerepoot, P., Nazari, R., & Salahpour, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.036 · Cited by 39
Lewis, A. S., & Picciotto, M. R. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3126-5 · Cited by 38
Nicotinic acetylcholine receptors in cancer: Limitations and prospects
Bele, T., Turk, T., & Križaj, I. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166875 · Cited by 38
Wang, X., Liu, Y., Wang, Q., Tsuruoka, M., Ohta, K., Wu, S., Yakushiji, M., & Inoue, T. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-0949-9 · Cited by 38
Lomazzo, E., Hussmann, G. P., Wolfe, B. B., Yasuda, R. P., Perry, D. C., & Kellar, K. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07408.x · Cited by 37
Gu, S., Knowland, D., Matta, J., O'Carroll, M. L., Davini, W. B., Dhara, M., Kweon, H.-J., & Bredt, D. (2020) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2013762117 · Cited by 35
Structural answers and persistent questions about how nicotinic receptors work
Gregg, B. W. (2008) · Frontiers in bioscience · doi:10.2741/3094 · Cited by 37
Nicotinic Acetylcholine Receptor α9 and α10 Subunits Are Expressed in the Brain of Mice
Lykhmus, O., Voytenko, L. P., Lips, K. S., Bergen, I., Krasteva‐Christ, G., Vetter, D. E., Kummer, W., & Skok, M. V. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00282 · Cited by 36
Hussmann, G. P., Turner, J. R., Lomazzo, E., Venkatesh, R., Cousins, V., Xiao, Y., Yasuda, R. P., Wolfe, B. B., Perry, D. C., Rezvani, A. H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.198085 · Cited by 34
Revisiting nicotine’s role in the ageing brain and cognitive impairment
Majdi, A., Kamari, F., Vafaee, M. S., & Sadigh‐Eteghad, S. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0008 · Cited by 35
Dau, A., Komal, P., Truong, M., Morris, G., Evans, G., & Nashmi, R. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-47 · Cited by 33
Nicotine alters mucin rheological properties
Chen, E. Y., Sun, A., Chen, C., Mintz, A. J., & Chin, W. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00396.2012 · Cited by 33
Fasoli, F., Moretti, M., Zoli, M., Pistillo, F., Crespi, A., Clementi, F., McClure‐Begley, T. D., Marks, M. J., & Gotti, C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.048 · Cited by 34
Heterogeneity of Reward Mechanisms
Lajtha, Á., & Sershen, H. W. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0096-4 · Cited by 33
Cellular events in nicotine addiction
Penton, R. E., & Lester, R. A. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.001 · Cited by 33
Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic α4β2 Receptors
Kishi, M., & Steinbach, J. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029298 · Cited by 31
Pollock, V. V., Pastoor, T., Katnik, C., Cuevas, J., & Wecker, L. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.032 · Cited by 31
Effects of Smoking Cessation on Pain in Older Adults
Shi, Y., Hooten, W. M., & Warner, D. O. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr097 · Cited by 31
Pathophysiology and Clinical Implications
Shi, Y., Weingarten, T. N., Mantilla, C. B., Hooten, W. M., & Warner, D. O. (2010) · Cited by 30
Pollock, V. V., Pastoor, T. E., & Wecker, L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04853.x · Cited by 29
Developmental Sex Differences in Nicotinic Currents of Prefrontal Layer VI Neurons in Mice and Rats
Alves, N. C., Bailey, C. D. C., Nashmi, R., & Lambe, E. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009261 · Cited by 33
Hosur, V., Leppanen, S., Taha, A. A., & Loring, R. H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06373.x · Cited by 29
Wooters, T. E., Smith, A. M., Pivavarchyk, M., Siripurapu, K. B., McIntosh, J. M., Zhang, Z., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01220.x · Cited by 28
Cooper, S. Y., & Henderson, B. J. (2020) · Molecules · doi:10.3390/molecules25184223 · Cited by 29
Kuryatov, A., Mukherjee, J. T., & Lindstrom, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062246 · Cited by 27
Riganti, L., Matteoni, C., Angelantonio, S. D., Nistri, A., Gaimarri, A., Sparatore, F., Canu, C., Clementi, F., & Gotti, C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706434 · Cited by 27
Uspenska, K., Lykhmus, O., Gergalova, G., Чернышов, В. И., Arias, H. R., Комісаренко, С. В., & Skok, M. V. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.07.009 · Cited by 27
Srinivasan, R., Richards, C. I., Dilworth, C. N., Moss, F. J., Dougherty, D. A., & Lester, H. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810022 · Cited by 26
Associated proteins: The universal toolbox controlling ligand gated ion channel function
Araud, T., Wonnacott, S., & Bertrand, D. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.017 · Cited by 26
Lange‐Asschenfeldt, C., Schäble, S., Suvorava, T., Gholamreza-Fahimi, E., Bisha, M., Stermann, T., Henning, U., & Kojda, G. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.025 · Cited by 26
Lykhmus, O., Kalashnyk, O., Uspenska, K., & Skok, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00359 · Cited by 26
Brain Region Specific Single-Molecule Fluorescence Imaging
Fu, X., Moonschi, F. H., Fox-Loe, A. M., Snell, A. A., Hopkins, D. M., Avelar, A. J., Henderson, B. J., Pauly, J. R., & Richards, C. I. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02133 · Cited by 25
The Concept of Allosteric Interaction and Its Consequences for the Chemistry of the Brain
Changeux, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.x113.503375 · Cited by 25
Self-citationWang, J., Kim, J.-M., Donovan, D. M., Becker, K. G., & Li, M. D. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.01.008 · Cited by 25
CRELD1 is an evolutionarily-conserved maturational enhancer of ionotropic acetylcholine receptors
D’Alessandro, M., Richard, M., Stigloher, C., Gache, V., Boulin, T., Richmond, J. E., & Bessereau, J. (2018) · eLife · doi:10.7554/elife.39649 · Cited by 25
Shameem, M., & Patel, A. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041824 · Cited by 24
Tobacco addiction: A biochemical model of nicotine dependence
Ortells, M. O., & Barrantes, G. E. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.11.004 · Cited by 26
DeDominicis, K. E., Sahibzada, N., Olson, T. T., Xiao, Y., Wolfe, B. B., Kellar, K. J., & Yasuda, R. P. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.106880 · Cited by 24
Hussmann, G. P., DeDominicis, K. E., Turner, J. R., Yasuda, R. P., Klehm, J., Forcelli, P. A., Xiao, Y., Richardson, J. R., Sahibzada, N., Wolfe, B. B., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12653 · Cited by 23
Gan, Q., Dai, J., Zhou, H., & Wollmuth, L. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686246 · Cited by 23
Uspenska, K., Lykhmus, O., Obolenskaya, M. Y., Pons, S., Maskos, U., Комісаренко, С. В., & Skok, M. V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00626 · Cited by 23
Self-citationWecker, L., Pollock, V. V., Pacheco, M. A., & Pastoor, T. E. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.005 · Cited by 23
?7 Nicotinic Acetylcholine Receptors: A Therapeutic Target in the Structure Era
Taly, A., & Charon, S. (2012) · Current Drug Targets · doi:10.2174/138945012800398919 · Cited by 23
Nicotinic acetylcholine receptors in mitochondria: subunit composition, function and signaling
(2016) · Neurotransmitter · doi:10.14800/nt.1290 · Cited by 23
Escubedo, E., Camarasa, J., Chipana, C., Garcia-Ratés, S., & Pubill, D. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88006-9 · Cited by 23
Nuutinen, S., Ekokoski, E., Lahdensuo, E., & Tuominen, R. K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.038 · Cited by 23
Mondoloni, S., Nguyen, C., Vicq, É., Ciscato, M., Jehl, J., Cuttoli, R. D.-D., Torquet, N., Tolu, S., Pons, S., Maskos, U., et al. (2023) · eLife · doi:10.7554/elife.80767 · Cited by 23
Self-citationeWang, P., Eshaq, R. S., Meshul, C. K., Moore, C., Hood, R. L., & Leidenheimer, N. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00188 · Cited by 21
Wang, F., Chen, H., & Sharp, B. M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05456.x · Cited by 21
Varenicline for smoking cessation
Tonstad, S. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.2.121 · Cited by 21
MicroRNA Regulation of nAChR Expression and Nicotine-Dependent Behavior in C. elegans
Rauthan, M., Gong, J., Liu, J., Li, Z., Wescott, S. A., Liu, J., & Xu, X. Z. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.043 · Cited by 21
Expression of cloned α6* nicotinic acetylcholine receptors
Wang, J., Kuryatov, A., & Lindstrom, J. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.009 · Cited by 21
Postsynaptic scaffolds for nicotinic receptors on neurons
Neff, R. A., Gómez‐Varela, D., Fernandes, C., & Berg, D. K. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.52 · Cited by 21
Regulation of Stability and Trafficking of Calcium-Sensing Receptors by Pharmacologic Chaperones
Huang, Y. S., Cavanaugh, A. H., & Breitwieser, G. E. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00007-5 · Cited by 18
Chemical crosslinkers enhance detection of receptor interactomes
Corgiat, B. A., Nordman, J. C., & Kabbani, N. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00171 · Cited by 18
Kusek, J., Yang, Q., Witek, M., Gruber, C. W., Nanoff, C., & Freissmuth, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094045 · Cited by 18
Qian, J., Mummalaneni, S., Alkahtani, R. M., Mahavadi, S., Murthy, K. S., Grider, J. R., & Lyall, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166565 · Cited by 18
Pharmacological Chaperones: Beyond Conformational Disorders
Leidenheimer, N. J. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_68 · Cited by 19
B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor
Post-Munson, D. J., Pieschl, R. L., Molski, T. F. P., Graef, J. D., Hendricson, A. W., Knox, R. J., McDonald, I. M., Olson, R. E., Macor, J. E., Weed, M. R., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.037 · Cited by 17
Beckmann, J. S., Meyer, A. C., Pivavarchyk, M., Horton, D. B., Zheng, G., Smith, A. M., Wooters, T. E., McIntosh, J. M., Crooks, P. A., Bardo, M. T., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1680-4 · Cited by 18
Govind, A. P., Vallejo, Y. F., Stolz, J. R., Yan, J.-Z., Swanson, G. T., & Green, W. N. (2017) · eLife · doi:10.7554/elife.25651 · Cited by 17
Corsini, S., Tortora, M., & Nistri, A. (2016) · The Journal of Physiology · doi:10.1113/jp272591 · Cited by 16
Tarren, J. R., Lester, H. A., Belmer, A., & Bartlett, S. E. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00338 · Cited by 16
Wigestrand, M. B., Mineur, Y., Heath, C. J., Fonnum, F., Picciotto, M. R., & Walaas, S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07415.x · Cited by 18
Hussmann, G. P., Yasuda, R. P., Xiao, Y., Wolfe, B. B., & Kellar, K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289546 · Cited by 16
Pubill, D., Garcia‐Ratés, S., Camarasa, J., & Escubedo, E. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.11.008 · Cited by 15
Smith, A. M., Pivavarchyk, M., Wooters, T. E., Zhang, Z., Zheng, G., McIntosh, J. M., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.018 · Cited by 15
Choline Promotes Nicotinic Receptor α4 + β2 Up-regulation
Gahring, L. C., Vasquez-Opazo, G. A., & Rogers, S. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108803 · Cited by 16
Lai, I., Porcu, A., Romoli, B., Keisler, M. N., Manfredsson, F. P., Powell, S. B., & Dulcis, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044204 · Cited by 14
Regional differential effects of chronic nicotine on brain α4-containing and α6-containing receptors
Even, N., Cardona, A., Soudant, M., Corringer, P., Changeux, J., & Cloëz-Tayarani, I. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3283112703 · Cited by 14
Self-citationImpact of Electronic Cigarette Vaping on Cerebral Ischemia: What We Know So Far
Siegel, J., Patel, S. H., Mankaliye, B., & Raval, A. P. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01011-w · Cited by 14
Mantione, M. E., Micheloni, S., Alcaino, C., New, K., Mazzaferro, S., & Bermúdez, I. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.172 · Cited by 12
miRNAome analysis of the mammalian neuronal nicotinic acetylcholine receptor gene family
Hogan, E. M., Casserly, A. P., Scofield, M. D., Mou, Z., Zhao-Shea, R., Johnson, C. W., Tapper, A. R., & Gardner, P. D. (2014) · RNA · doi:10.1261/rna.034066.112 · Cited by 13
Koranda, J. L., Krok, A. C., Xu, J., Contractor, A., McGehee, D. S., Beeler, J. A., & Zhuang, X. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2754-15.2016 · Cited by 13
Zarate, S. M., Garcia, R. C., Pandey, G., & Srinivasan, R. (2025) · npj Parkinson's Disease · doi:10.1038/s41531-024-00855-3 · Cited by 10
Universal nature of cholinergic regulation demonstrated with nicotinic acetylcholine receptors
Skok, M. V. (2022) · BBA Advances · doi:10.1016/j.bbadva.2022.100061 · Cited by 11
Smoking flies: testing the effect of tobacco cigarettes on heart function ofDrosophila melanogaster
Santalla, M., Pagola, L., Gómez, I., Balcazar, D., Valverde, C. A., & Ferrero, P. (2021) · Biology Open · doi:10.1242/bio.055004 · Cited by 11
Zhang, H. J., Zammit, M. D., Kao, C.-M., Govind, A. P., Mitchell, S. J., Holderman, N., Bhuiyan, M. P. I., Freifelder, R. H., Kucharski, A., Zhuang, X., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2484-21.2022 · Cited by 12
Llabrés, S., Garcia‐Ratés, S., Cristóbal‐Lecina, E., Riéra, A., Borrell, J. I., Camarasa, J., Pubill, D., Luque, F. J., & Escubedo, E. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.044 · Cited by 11
Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia
Zimmerman, C. N., Jaunarajs, K. L. E., Meringolo, M., Rizzo, F. R., Santoro, M., Standaert, D. G., & Pisani, A. (2017) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2017.00043 · Cited by 10
Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits
Vieira‐Brock, P. L., McFadden, L. M., Nielsen, S. M., Ellis, J. D., Walters, E. T., Stout, K. A., McIntosh, J. M., Wilkins, D. G., Hanson, G. R., & Fleckenstein, A. E. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221945 · Cited by 10
Hydrophobic Photolabeling Studies Identify the Lipid−Protein Interface of the 5-HT3AReceptor
Sanghvi, M., Hamouda, A. K., Davis, M. I., Morton, R. A., Srivastava, S., Pandhare, A., Duddempudi, P. K., Machu, T. K., Lovinger, D. M., Cohen, J. B., et al. (2009) · Biochemistry · doi:10.1021/bi901208j · Cited by 10
Acetylcholine Receptor Structure
Luo, J., & Lindstrom, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-73585-6_2 · Cited by 11
Metadata
- Authors
- Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Changeux, Jean-Pierre
- Corringer, Pierre Jean
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 46
- Issue
- 4
- Pages
- 595-607
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W1994720205
- Cited by
- 261
- References
- 46
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 8 · 2018: 6 · 2017: 11 · 2016: 17 · 2015: 11 · 2014: 18 · 2013: 19 · 2012: 16
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2999 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotine, nicotinic acetylcholine receptors, alpha4beta2 receptor, receptor up-regulation, glycosylation, high-mannose glycosylation, endoplasmic reticulum, receptor trafficking, nicotine dependence, neuroplasticity
- MeSH terms
- Antibodies, Autoradiography, Binding, Competitive, Carbachol, Cell Line, Dihydro-beta-Erythroidine, Dose-Response Relationship, Drug, Drug Interactions, Fluorescent Antibody Technique, Glycosylation, Humans, Membrane Potentials, Models, Biological, Nicotine, Protein Binding, Pyridines, Receptors, Nicotinic, Time Factors, Transfection, Tritium, Blotting, Western, Up-Regulation, Patch-Clamp Techniques, Nicotinic Agonists, Nicotinic Antagonists, Bridged Bicyclo Compounds, Heterocyclic, Protein Subunits, Intracellular Space, Immunoprecipitation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
